substance p has been researched along with Alloxan Diabetes in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (11.94) | 18.7374 |
| 1990's | 57 (42.54) | 18.2507 |
| 2000's | 25 (18.66) | 29.6817 |
| 2010's | 30 (22.39) | 24.3611 |
| 2020's | 6 (4.48) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, M; Li, Q; Liu, Y; Lu, M; Xia, Y; Xu, B; Xu, T; Yu, Z | 1 |
| Dai, C; Hou, X; Liu, N; Qian, W; Yan, C; Yang, P | 1 |
| Block, M; Gharraee, N; Goslen, KH; Kavanagh, K; Lacy, JL; Levick, SP; Meléndez, GC; Whitfield, J; Widiapradja, A | 1 |
| Chen, W; Jia, Y; Liang, C; Luo, H; Quan, X; Wang, J; Wang, Y | 1 |
| Czuwara, J; Kosson, P; Lipiński, PFJ; Matalińska, J; Muchowska, A; Redkiewicz, P; Różycki, K | 1 |
| Boodhoo, K; Myburgh, KH; Tabb, DL; van de Vyver, M; Vlok, M | 1 |
| Park, KS; Um, J; Yu, J | 1 |
| Jung, Y; Kim, JE; Kim, SH; Lee, JH | 1 |
| Gopal, A; Kant, V; Kumar, D; Kumar, P; Pathak, NN; Prasad, R; Tandan, SK | 2 |
| Byeon, Y; Dubon, MJ; Jung, N; Kim, D; Kim, DY; Park, KS; Son, Y; Um, J | 1 |
| Chen, L; Guo, Z; Li, TP; Liu, CJ; Sun, T; Zhao, X | 1 |
| Cho, SW; Jeon, EJ; Jung, Y; Kuai, R; Moon, JJ; Park, HJ; Schwendeman, A; Seo, Y | 1 |
| Choi, S; Jung, N; Kim, D; Lee, SH; Park, KS; Son, Y; Um, J | 1 |
| Bulc, M; Całka, J; Palus, K; Zielonka, Ł | 1 |
| Altdorfer, K; Batbayar, B; Fehér, E; Hevér, H; Zelles, T | 1 |
| Guo, Z; Meng, XX; Xie, LS; Yang, JH; Zhang, T | 1 |
| Danielson, P; Di, G; Duan, H; Qi, X; Qu, M; Wang, Y; Xie, L; Yang, L; Zhou, Q | 1 |
| Auster, ME; Carvalho, E; Kafanas, A; Kearney, C; Kokkotou, E; Kuchibhotla, S; Leal, EC; LoGerfo, FW; Mooney, DJ; Pradhan-Nabzdyk, L; Tecilazich, F; Tellechea, A; Veves, A | 1 |
| Altdorfer, K; Fehér, E; Kispély, B | 1 |
| Albiero, M; Avogaro, A; Canal, F; Cappellari, R; Carnelli, F; Dang, Z; Emanueli, C; Fadini, GP; Falco, A; Furlan, A; Lorusso, B; Madeddu, P; Maselli, D; Ou, K; Paccagnella, A; Paiola, E; Quaini, F; Rodriguez-Arabaolaza, I; Rosa, F; Sambataro, M; Sangalli, E; Seganfreddo, E; Specchia, C; Spinetti, G | 1 |
| Hong, HS; Kim, S; Park, JH; Son, Y | 1 |
| Gulak, KL; Paduraru, ON; Philyppov, IB; Prevarskaya, N; Shuba, YM; Skryma, R | 1 |
| De Smet, B; Depoortere, I; Moechars, D; Peeters, TL; Saels, I; Thijs, T; Ver Donck, L; Verhulst, PJ | 1 |
| Chiang, H; Hsieh, ST; Hsieh, YL; Lin, WM; Lin, YY; Luo, KR; Tseng, TJ | 1 |
| Carlsson, A; Hallberg, M; Kamei, J; Nyberg, F; Ohsawa, M | 1 |
| Andersen, ND; Cai, X; Guthrie, P; Logerfo, FW; Malek, J; Martin, M; Pradhan, L; Veves, A; Wu, S | 1 |
| Laudon, V; Li, Y; Liu, Y; Shi, B; Wang, D; Wang, P; Zhang, J | 1 |
| Boer, PA; Gontijo, JA; Mesquita, FF; Rossi, Cde L | 1 |
| Birklein, F; Fuchs, D; Reeh, PW; Sauer, SK | 1 |
| Asato, M; Carlsson, A; Fransson, R; Hallberg, M; Kamei, J; Koizumi, T; Nakanishi, Y; Nyberg, F; Ohsawa, M; Sandström, A | 1 |
| Chen, H; Lu, MY; Ren, JY; Song, JX | 1 |
| Amendoeira, FC; Batista, MM; Carvalho, VF; Cordeiro, RS; de O Barreto, E; E Silva, PM; Florim, LT; Martins, MA; Torres, RC | 1 |
| Bosch, F; De Giorgio, R; Domènech, A; Gori, A; Jiménez, M; Pasquinelli, G; Pumarola, M | 1 |
| Akerman, KE; Chapman, H; Hukkanen, M; Koivisto, A; Kuokkanen, K; Lindstedt, K; Pertovaara, A; Saarnilehto, M; Viisanen, H; Wei, H | 1 |
| Que, HF; Wang, YF | 1 |
| Kovács, P; Németh, J; Paragh, G; Peitl, B; Sári, R; Szilvássy, Z; Vígh, L | 1 |
| Li, YT; Liu, DW; Peng, Y; Xu, JC; Zhang, HY; Zhong, QL; Zhu, FB | 1 |
| Aki, FT; Cetinkaya, M; Gür, S; Oztekin, V; Oztürk, B; Ugurlu, O | 1 |
| Batbayar, B; Fehér, E; Somogyi, J; Zelles, T | 1 |
| Ahmad, T; Bileviciute-Ljungar, I; Finn, A; Kreicbergs, A; Li, J; Ostenson, CG; Ugarph-Morawski, A | 1 |
| Chin, S; Otsuki, S; Uehara, K; Yagihashi, S; Yamagishi, S | 1 |
| Gabra, BH; Sirois, P | 1 |
| Ji, M; Lin, L; Lin, Z; Zhang, HJ; Zhao, ZQ | 1 |
| Kakinoki, B; Ohgami, T; Saito, K; Sejima, M; Sekimoto, S; Yamagami, K; Yuki, S | 1 |
| Calcutt, NA; Freshwater, JD; Hauptmann, N; Mizisin, AP; Taylor, EM | 1 |
| Ekberg, K; Kamiya, H; Sima, AA; Wahren, J; Zhang, W | 1 |
| Batbayar, B; Fehér, E; Vér, A; Zelles, T | 1 |
| Davidson, ME; Lang, RJ | 1 |
| Cicha, MZ; Kopp, UC; Yorek, MA | 1 |
| Brewster, WJ; Diemel, LT; Leach, RM; Tomlinson, DR | 1 |
| Apfel, SC; Arezzo, JC; Brownlee, M; Federoff, H; Kessler, JA | 1 |
| Brewster, WJ; Diemel, LT; Fernyhough, P; Tomlinson, DR | 2 |
| Ciambotti, J; de Groat, WC; Mackway-Gerardi, AM; Steers, WD | 1 |
| Hikawa, N; Horie, H; Inoue, S; Sango, K; Sotelo, JR; Takenaka, T; Tanaka, S; Verdes, JM | 1 |
| Serova, ON | 1 |
| Bolego, C; Pinna, C; Puglisi, L | 2 |
| Echtenkamp, SF; Marfurt, CF | 1 |
| Cruwys, SC; Garrett, NE; Kidd, BL; Tomlinson, DR | 1 |
| Ohkubo, Y; Takeshita, N; Yamaguchi, I | 1 |
| Hitosugi, H; Kamei, J; Kasuya, Y | 3 |
| Belai, A; Burnstock, G; Soediono, P | 1 |
| Davison, JS; Mathison, R | 2 |
| Inoue, K; Kamata, K; Kasuya, Y | 1 |
| Aberdeen, J; Belai, A; Burnstock, G; Milner, P | 1 |
| Markle, RA; Walker, DK | 1 |
| Belai, A; Burnstock, G; Calcutt, NA; Carrington, AL; Diemel, LT; Tomlinson, DR | 1 |
| Belai, A; Burnstock, G | 2 |
| Kream, RM; Leeman, SE; Marchand, JE; Markle, RA; Rittenhouse, PA | 1 |
| Chen, J; Kream, RM; Leeman, SE; Marchand, JE; Rittenhouse, PA | 1 |
| Dewhurst, M; Garrett, NE; Malcangio, M; Tomlinson, DR | 1 |
| Mayhan, WG | 1 |
| Gobeil, F; Nguyen-Le, XK; Nsa Allogho, S; Pheng, LH; Regoli, D | 1 |
| Diemel, LT; Fernyhough, P; Tomlinson, DR | 1 |
| Cook, JA; Vilensky, JA | 1 |
| Boden, P; Field, MJ; Hughes, J; McCleary, S; Singh, L; Suman-Chauhan, N | 1 |
| Corder, R; Horrobin, DF; Hounsom, L; Tomlinson, DR; Tritschler, H | 1 |
| Malcangio, M; Tomlinson, DR | 1 |
| Bennett, GS; Brain, SD; Diemel, LT; Garrett, NE; Tomlinson, DR | 1 |
| Klitzsch, T; Pera, S; Reiter, R; Unger, JW | 1 |
| Brewster, WJ; Diemel, LT; Fernandes, K; Fernyhough, P; Tomlinson, DR | 1 |
| Mayhan, WG; Patel, KP | 1 |
| Nemeth, J; Oroszi, G; Sari, R; Szilvassy, Z; Szolcsanyi, J; Than, M | 1 |
| Adeghate, E | 2 |
| Di Giulio, AM; Germani, E; Gorio, A; Lesma, E | 1 |
| Humpel, C; Kieselbach, G; Kralinger, M; Kremser, B; Kunze, C; Philipp, W; Teuchner, B; Troger, J | 1 |
| Bassirat, M; Khalil, Z | 1 |
| Calcutt, NA; Gustafsson, H; Malmberg, AB; Stiller, C | 1 |
| Adeghate, E; Ponery, AS | 1 |
| Adeghate, E; Pallot, DJ; Ponery, AS; Singh, J | 1 |
| Riaz, SS; Tomlinson, DR | 1 |
| Baldissera, I; Griesser, U; Heufler, C; Huemer, H; Kieselbach, G; Kralinger, M; Kremser, B; Neyer, S; Schmid, E; Troger, J | 1 |
| Cabrini, DA; Calixto, JB; Campos, MM; Cardozo, AH; Rae, GA; Toro, JH | 1 |
| El-Salhy, M; Forsgren, S; Spångéus, A | 1 |
| Corder, R; Hounsom, L; Patel, J; Tomlinson, DR | 1 |
| Itoh, H; Makino, I; Miyamoto, Y; Morikawa, A; Yoneda, M | 1 |
| Horvath, P; Kovács, P; Németh, J; Sziklai, I; Szilasi, M; Szilvássy, J; Szilvássy, Z | 1 |
| Cabrini, DA; Calixto, JB; Campos, MM; Cardozo, AH; Huidobro-Toro, JP; Rae, GA | 1 |
| Aoki, T; Hitosugi, H; Kamei, J; Kasuya, Y; Kawashima, N; Ohhashi, Y | 1 |
| Ahlman, H; Dahlstrand, C; Dahlström, A; Jonsson, O; Lundstam, S; Norlén, L; Pettersson, S | 1 |
| Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Mantegazza, P; Tenconi, B | 1 |
| Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Maccari, F; Mantegazza, P; Ramacci, MT; Tenconi, B | 1 |
| Bertelli, A; Di Giulio, AM; Ferraris, L; Gorio, A; Mantegazza, P; Ramacci, MT | 1 |
| Diemel, LT; Stevens, EJ; Tomlinson, DR; Willars, GB | 1 |
| Andersson, PO; Fahrenkrug, J; Malmgren, A; Uvelius, B | 1 |
| Kamei, J; Kasuya, Y; Ogawa, M | 1 |
| Calcutt, NA; Keen, P; Tomlinson, DR; Willars, GB | 1 |
| Francavilla, S; Karanth, SS; Mirrlees, DJ; Polak, JM; Springall, DR | 1 |
| Aoki, T; Kamei, J; Kasuya, Y; Ohhashi, Y | 1 |
| Homma, S; Ito, S; Karakida, T; Sakai, M; Yamada, Y | 1 |
| Kamei, J; Kasuya, Y; Ogawa, Y; Ohhashi, Y | 1 |
| Ballmann, M; Conlon, JM | 1 |
| Belai, A; Burnstock, G; Crowe, R; Lincoln, J; Loesch, A; Milner, P | 1 |
| Gamse, R; Jancsó, G | 1 |
| MacLean, DB | 1 |
| Belai, A; Burnstock, G; Lincoln, J | 1 |
| Burnstock, G; Crowe, R; Lincoln, J; Milner, P | 1 |
| Keen, P; Robinson, JP; Tomlinson, DR; Willars, GB | 2 |
| Anand, P; Bloom, SR; Gillon, KR; Lisk, R; Llewelyn, JG; Thomas, PK | 1 |
| Belai, A; Burnstock, G; Lincoln, J; Milner, P | 1 |
| Burnstock, G; Crowe, R | 1 |
| Calcutt, NA; Clarke, HE; Compton, AM; Keen, P; Macdonald, IA; Tomlinson, DR; Willars, GB | 1 |
| Homma, S; Karakida, T; Liu, HS | 1 |
| Calcutt, NA; Compton, AM; Keen, P; Tomlinson, DR; Willars, GB | 1 |
| Chang, KS; Li, XS; Tanz, RD | 1 |
| Abbracchio, MP; Cattabeni, F; Di Giulio, AM; Gorio, A; La Croix, R; Mantegazza, P; Tenconi, B | 1 |
1 review(s) available for substance p and Alloxan Diabetes
| Article | Year |
|---|---|
Neurogenic acceleration of osteoarthritis.
Topics: Animals; Autonomic Nervous System; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Electrophysiology; Humans; Nervous System; Neuropeptides; Osteoarthritis; Proprioception; Substance P | 1998 |
133 other study(ies) available for substance p and Alloxan Diabetes
| Article | Year |
|---|---|
Hypoglycemic Effect of Electroacupuncture at ST25 Through Neural Regulation of the Pancreatic Intrinsic Nervous System.
Topics: Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Electroacupuncture; Hypoglycemia; Inflammation; Insulin; Insulin Resistance; Insulin-Secreting Cells; Rats; Rats, Sprague-Dawley; Substance P; TRPV Cation Channels | 2022 |
Effects of Simo decoction on gastric motility of diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Gastric Emptying; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 2022 |
Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes.
Topics: Animals; Cardiomyopathies; Chlorocebus aethiops; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Fibrosis; Mice; Myocardium; Stroke Volume; Substance P; Ventricular Function, Left | 2023 |
Downregulation of BDNF-TrkB signaling may contribute to the colonic motility disorders in mice with streptozocin-induced diabetes.
Topics: Animals; Brain-Derived Neurotrophic Factor; Colonic Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Down-Regulation; Mice; Streptozocin; Substance P | 2023 |
The analgesic hybrid of dermorphin/substance P and analog of enkephalin improve wound healing in streptozotocin-induced diabetic rats.
Topics: Analgesics; Animals; Collagen; Diabetes Mellitus, Experimental; Enkephalins; Epidermal Cells; Fibroblasts; Macrophages; Male; Neovascularization, Physiologic; Opioid Peptides; Peptide Fragments; Rats; Rats, Wistar; Substance P; Wound Healing | 2020 |
Dysregulated healing responses in diabetic wounds occur in the early stages postinjury.
Topics: Animals; Body Fluids; Chronic Disease; Cytokines; Diabetes Mellitus, Experimental; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Obese; Proteome; Substance P; Wound Healing; Wounds and Injuries | 2021 |
Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bone Marrow; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Progenitor Cells; Immunohistochemistry; Injections, Subcutaneous; Male; Mice; Neovascularization, Physiologic; Phosphoproteins; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Substance P; Wound Healing; YAP-Signaling Proteins | 2017 |
Skin Regeneration with Self-Assembled Peptide Hydrogels Conjugated with Substance P in a Diabetic Rat Model.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Hydrogels; Peptides; Rats; Rats, Sprague-Dawley; Skin; Substance P; Wound Healing | 2018 |
Combined effect of substance P and curcumin on cutaneous wound healing in diabetic rats.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Biomarkers; Curcumin; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Male; Neurotransmitter Agents; Rats; Rats, Wistar; Skin; Substance P; Treatment Outcome; Wound Healing; Wounds and Injuries | 2017 |
Substance P preserves pancreatic β-cells in streptozotocin-induced type 1 diabetic mice.
Topics: Acute Disease; Animals; Apoptosis; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Pancreatitis; Streptozocin; Structure-Activity Relationship; Substance P | 2017 |
Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Substance P | 2017 |
High-density lipoprotein-mimicking nanodiscs carrying peptide for enhanced therapeutic angiogenesis in diabetic hindlimb ischemia.
Topics: Animals; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Hindlimb; Ischemia; Lipoproteins, HDL; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Peptides; Substance P | 2018 |
Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hyperglycemia; Immunomodulation; Insulin-Secreting Cells; Male; Mice, Inbred NOD; Pancreatic Stellate Cells; Substance P | 2018 |
Changes in Immunoreactivity of Sensory Substances within the Enteric Nervous System of the Porcine Stomach during Experimentally Induced Diabetes.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Enkephalin, Leucine; Enteric Nervous System; Female; Fluorescent Antibody Technique; Neurons; Neuropeptides; Stomach; Streptozocin; Substance P; Sus scrofa | 2018 |
[Changes in the innervation of the taste buds in diabetic rats].
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Galanin; Hypoglycemic Agents; Immunohistochemistry; Insulin; Lymphocyte Count; Male; Mast Cells; Nerve Endings; Neuropeptide Y; Rats; Rats, Inbred Strains; Streptozocin; Substance P; Taste Buds; Time Factors; Vasoactive Intestinal Peptide | 2013 |
Restoration of endogenous substance P is associated with inhibition of apoptosis of retinal cells in diabetic rats.
Topics: Animals; Apoptosis; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gene Expression; Male; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Substance P | 2013 |
Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor.
Topics: Animals; Cell Line; Cornea; Corneal Injuries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epithelial Cells; ErbB Receptors; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neurotransmitter Agents; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Neurokinin-1; Sirtuin 1; Substance P; Touch; Wound Healing | 2014 |
Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats.
Topics: Administration, Topical; Animals; Axons; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; GAP-43 Protein; Gene Expression Regulation; Heme Oxygenase-1; Interleukin-10; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Neovascularization, Physiologic; Nerve Fibers; Nerve Regeneration; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats, Wistar; RNA, Messenger; Streptozocin; Substance P; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2015 |
Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Inflammation; Macrophages; Mice; Rabbits; Receptors, Neurokinin-1; Skin; Substance P; Wound Healing | 2015 |
[Changes of the innervation in the mucous membrane and glands of the tongue in early and late experimental diabetes mellitus].
Topics: Animals; Autonomic Fibers, Postganglionic; Diabetes Mellitus, Experimental; Inflammation; Lymphocytes; Male; Mast Cells; Mouth Mucosa; Neuropeptide Y; Neurotransmitter Agents; Plasma Cells; Rats; Rats, Wistar; Salivary Glands; Streptozocin; Substance P; Time Factors; Tongue | 2015 |
Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Hematopoietic Stem Cells; Humans; Mice; Nociception; Sensory Receptor Cells; Substance P | 2015 |
Substance P promotes diabetic wound healing by modulating inflammation and restoring cellular activity of mesenchymal stem cells.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Inflammation; Interleukin-10; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Neurotransmitter Agents; Substance P; Tumor Necrosis Factor-alpha; Wound Healing; Wounds and Injuries | 2016 |
TRPA1-dependent regulation of bladder detrusor smooth muscle contractility in normal and type I diabetic rats.
Topics: Animals; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Male; Muscle Contraction; Muscle, Smooth; Prostaglandins; Rats, Wistar; Streptozocin; Substance P; TRPA1 Cation Channel; TRPC Cation Channels; TRPV Cation Channels; Urinary Bladder | 2016 |
Role of ghrelin in the relationship between hyperphagia and accelerated gastric emptying in diabetic mice.
Topics: Acetylcholine; Agouti-Related Protein; Animals; Blood Glucose; Body Weight; Cholinergic Agents; Diabetes Mellitus, Experimental; Eating; Gastric Emptying; Gastric Fundus; Ghrelin; Hyperphagia; Hypothalamus; Male; Mice; Mice, Knockout; Muscle Contraction; Neuropeptide Y; Neurotransmitter Agents; Pro-Opiomelanocortin; Receptors, Ghrelin; RNA, Messenger; Substance P | 2008 |
Depletion of peptidergic innervation in the gastric mucosa of streptozotocin-induced diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Gastric Mucosa; Male; Peptides; Rats; Rats, Sprague-Dawley; Substance P | 2008 |
Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.
Topics: Amino Acid Sequence; Animals; Diabetes Mellitus, Experimental; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Peptide Fragments; Receptors, sigma; Substance P; Temperature | 2010 |
Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing.
Topics: Alloxan; Animals; Cytokines; Diabetes Mellitus, Experimental; Disease Models, Animal; Inflammation; Interleukin-6; Interleukin-8; Neuropeptide Y; Neuropeptides; Rabbits; Substance P; Wound Healing | 2011 |
Nerve growth factor and substance P: expression in a rat model of diabetic bladder.
Topics: Animals; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Gene Expression; Immunohistochemistry; Male; Nerve Growth Factor; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Substance P; Urinary Bladder Diseases | 2011 |
Early potential impairment of renal sensory nerves in streptozotocin-induced diabetic rats: role of neurokinin receptors.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Ganglia, Spinal; Kidney; Male; Neurons; Neuropeptides; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, Neurokinin-1; Sensory Receptor Cells; Substance P; Vasodilator Agents | 2011 |
Sensitized peripheral nociception in experimental diabetes of the rat.
Topics: Action Potentials; Animals; Behavior, Animal; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; In Vitro Techniques; Male; Nerve Fibers; Nociceptors; Pain Measurement; Pain Threshold; Rats; Reaction Time; Sciatic Nerve; Skin; Streptozocin; Substance P | 2010 |
The effect of substance P1-7 amide on nociceptive threshold in diabetic mice.
Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Injections, Spinal; Mice; Mice, Inbred ICR; Nociceptors; Pain Measurement; Pain Threshold; Peptide Fragments; Substance P | 2011 |
Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.
Topics: Animals; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Capsaicin; Coronary Vessels; Diabetes Mellitus, Experimental; Heart; In Vitro Techniques; Ischemic Postconditioning; Male; Myocardial Reperfusion Injury; Myocardium; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Rats; Rats, Sprague-Dawley; Substance P; TRPV Cation Channels; Ventricular Function | 2011 |
Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
Topics: Animals; Antigens; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Cell Count; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Insulin; Male; Mast Cells; Mesentery; Peritoneal Cavity; Pleural Cavity; Rats; Rats, Wistar; Substance P | 2011 |
Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice.
Topics: Animals; Choline O-Acetyltransferase; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Models, Animal; Gastric Emptying; Gastrointestinal Motility; Ileum; Interferon-beta; Male; Mice; Mice, Transgenic; Myenteric Plexus; Nitric Oxide Synthase Type I; Receptor-Interacting Protein Serine-Threonine Kinases; Streptozocin; Substance P; Vasoactive Intestinal Peptide | 2011 |
Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.
Topics: Animals; Calcium Channels; Calcium Signaling; Diabetes Mellitus, Experimental; Diabetic Nephropathies; HEK293 Cells; Humans; Male; Membrane Potentials; Nerve Fibers; Nerve Tissue Proteins; Neural Conduction; Neurons, Afferent; Pain Threshold; Rats; Reflex; Sensory System Agents; Skin; Substance P; Time Factors; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPC Cation Channels | 2012 |
[Effects of Chinese herbal medicine Yiqi Huayu formula on substance P expression in skin ulcers of rats with diabetes mellitus].
Topics: Animals; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Male; Phytotherapy; Rats; Rats, Sprague-Dawley; Skin Ulcer; Substance P; Up-Regulation; Wound Healing | 2011 |
Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
Topics: Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucose Clamp Technique; Insulin; Insulin Resistance; Male; Neural Conduction; Rats; Rats, Wistar; Sensory Receptor Cells; Somatostatin; Substance P | 2012 |
[Effect of substance P combined with epidermal stem cells on wound healing and nerve regeneration in rats with diabetes mellitus].
Topics: Animals; Diabetes Mellitus, Experimental; Epithelial Cells; Nerve Regeneration; Rats; Rats, Sprague-Dawley; Stem Cells; Substance P; Wound Healing | 2012 |
The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder.
Topics: Adenosine Triphosphate; Animals; Carbachol; Diabetes Mellitus, Experimental; Electric Stimulation; Female; Muscle Contraction; Muscle, Smooth; Rats; Substance P; Urinary Bladder; Urinary Bladder Neck Obstruction | 2002 |
Immunohistochemical analysis of substance P containing nerve fibres and their contacts with mast cells in the diabetic rat's tongue.
Topics: Animals; Diabetes Mellitus, Experimental; Humans; Immunohistochemistry; Male; Mast Cells; Neurons, Afferent; Rats; Streptozocin; Substance P; Tongue | 2003 |
Bone and joint neuropathy in rats with type-2 diabetes.
Topics: Animals; Bone and Bones; Bone Marrow; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Female; Ganglia, Spinal; Glucose Tolerance Test; Immunohistochemistry; Joints; Neuropeptide Y; Neuropeptides; Peripheral Nervous System Diseases; Radioimmunoassay; Rats; Rats, Wistar; Substance P | 2004 |
Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice.
Topics: Actins; Aldehyde Reductase; Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Ganglia, Spinal; Humans; Imidazolidines; Isoenzymes; Mice; Mice, Transgenic; Neural Conduction; Neurons; Protein Kinase C; Reference Values; Substance P | 2004 |
Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice.
Topics: Animals; Bradykinin B1 Receptor Antagonists; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Male; Mice; Nitric Oxide Synthase; Receptor, Bradykinin B1; Signal Transduction; Streptozocin; Substance P | 2004 |
Effect of erythromycin on gastric dysmotility and neuroendocrine peptides in rats with diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Male; Motilin; Muscle Contraction; Muscle, Smooth; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2005 |
Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Growth Factor; Neural Conduction; Neuroprotective Agents; PC12 Cells; Peripheral Nervous System Diseases; Phosphorylation; Rats; Rats, Wistar; Receptor, trkA; Sialic Acids; Skin; Streptozocin; Substance P; Ubiquitin Thiolesterase | 2006 |
Protection of sensory function in diabetic rats by Neotrofin.
Topics: Aminobenzoates; Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Hypoxanthines; Nerve Growth Factor; Neural Conduction; Neurons, Afferent; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Skin; Spinal Nerve Roots; Streptozocin; Substance P; Time Factors | 2006 |
C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Topics: Animals; C-Peptide; Calcitonin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Fibers; Nerve Regeneration; Neuritis; Neurons; Rats; Rats, Inbred BB; Reference Values; Substance P | 2006 |
Changes of the different neuropeptide-containing nerve fibers and immunocells in the diabetic rat's alimentary tract.
Topics: Animals; Diabetes Mellitus, Experimental; Digestive System; Male; Nerve Fibers; Neuropeptide Y; Neuropeptides; Rats; Rats, Wistar; Substance P; Tyrosine 3-Monooxygenase | 2006 |
Pelviureteric peristaltic contractions in diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Humans; In Vitro Techniques; Kidney Pelvis; Male; Matched-Pair Analysis; Muscle Contraction; Muscle Strength; Muscle, Smooth; Neurokinin A; Neurotransmitter Agents; Peristalsis; Rats; Rats, Wistar; Sensory System Agents; Substance P; Ureter | 2007 |
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Baroreflex; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Kidney; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Substance P | 2008 |
Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia co-exist with normal messenger RNA levels in the lumbar dorsal root ganglia.
Topics: Animals; Blood Glucose; Blotting, Northern; Body Weight; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Ganglia, Spinal; Hypoxia; Male; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Sciatic Nerve; Substance P; Tachykinins | 1994 |
Nerve growth factor administration protects against experimental diabetic sensory neuropathy.
Topics: Action Potentials; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Nerve Growth Factors; Rats; Rats, Wistar; Substance P | 1994 |
Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor.
Topics: Animals; Blotting, Northern; Brain-Derived Neurotrophic Factor; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Ganglia, Spinal; Male; Nerve Growth Factors; Nerve Tissue Proteins; Neuropeptides; Protein Precursors; Rats; Rats, Wistar; Reference Values; RNA, Messenger; Substance P; Tachykinins | 1994 |
Alterations in neural pathways to the urinary bladder of the rat in response to streptozotocin-induced diabetes.
Topics: Afferent Pathways; Animals; Axons; Diabetes Mellitus, Experimental; Diuresis; Efferent Pathways; Female; Fluorescent Dyes; Ganglia, Autonomic; Ganglia, Spinal; Histocytochemistry; Horseradish Peroxidase; Pelvis; Radioimmunoassay; Rats; Rats, Wistar; Stilbamidines; Substance P; Urinary Bladder; Vasoactive Intestinal Peptide; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate; Wheat Germ Agglutinins | 1994 |
Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; DNA Probes; Gene Expression; Insulin; Male; Nerve Growth Factors; Neuropeptides; Rats; Rats, Wistar; Reference Values; RNA, Messenger; Sciatic Nerve; Substance P | 1994 |
Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro.
Topics: Animals; Calcitonin Gene-Related Peptide; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Nerve Growth Factors; Nerve Tissue Proteins; Neurons, Afferent; Streptozocin; Substance P | 1994 |
[Systemic activity of taste receptors].
Topics: Animals; Cholecystokinin; Diabetes Mellitus, Experimental; Food Preferences; Mechanoreceptors; Mice; Rats; Sodium Chloride; Stomach; Substance P; Sympathetic Nervous System; Taste; Taste Buds; Taste Threshold | 1994 |
Effect of substance P and capsaicin on urinary bladder of diabetic rats and the role of the epithelium.
Topics: Acetylcholine; Animals; Blood Glucose; Body Weight; Capsaicin; Diabetes Mellitus, Experimental; Epithelium; In Vitro Techniques; Male; Muscle, Smooth; Organ Size; Prostaglandins; Rats; Rats, Sprague-Dawley; Substance P; Time Factors; Urinary Bladder | 1994 |
The effect of diabetes on neuropeptide content in the rat cornea and iris.
Topics: Animals; Calcitonin Gene-Related Peptide; Cornea; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Immunoenzyme Techniques; Iris; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 1995 |
Effect of substance P and capsaicin on stomach fundus and ileum of streptozotocin-diabetic rats.
Topics: Acetylcholine; Age Factors; Animals; Capsaicin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gastric Fundus; Ileum; In Vitro Techniques; Male; Muscle Contraction; Rats; Rats, Sprague-Dawley; Streptozocin; Substance P | 1995 |
Streptozotocin-induced diabetes decreases substance P levels in experimental arthritis in the rat knee.
Topics: Animals; Arthritis; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Ganglia, Spinal; Immunohistochemistry; Knee Joint; Rats; Substance P; Time Factors | 1995 |
Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
Topics: Animals; Central Nervous System; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dopamine Antagonists; Female; Fenclonine; Indoles; Injections, Spinal; Ketanserin; Male; Mice; Nociceptors; Pain; Pain Measurement; Pindolol; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Synaptic Transmission; Tiapamil Hydrochloride; Tropisetron | 1995 |
Nociceptive responses to intrathecally administered substance P and somatostatin in diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Pain Measurement; Pain Threshold; Somatostatin; Substance P | 1993 |
Prevention of neuropathy in the pyloric sphincter of streptozotocin-diabetic rats by gangliosides.
Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Fluorescent Antibody Technique; Gangliosides; Male; Neurons; Neuropeptide Y; Pylorus; Rats; Rats, Wistar; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1993 |
Formalin-induced nociceptive responses in diabetic mice.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Receptors, Opioid, delta; Substance P | 1993 |
Attenuated plasma extravasation to sensory neuropeptides in diabetic rats.
Topics: Amino Acid Sequence; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Capillary Permeability; Diabetes Mellitus, Experimental; Male; Molecular Sequence Data; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Serum Albumin; Substance P | 1993 |
Effects of mexiletine on formalin-induced nociceptive responses in mice.
Topics: Animals; Diabetes Mellitus, Experimental; Formaldehyde; Injections, Intraperitoneal; Injections, Spinal; Male; Mexiletine; Mice; Mice, Inbred ICR; Nociceptors; Pain; Somatostatin; Streptozocin; Substance P | 1993 |
Changes in contractile responses of the urinary bladder to substance P in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Capsaicin; Diabetes Mellitus, Experimental; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Organ Size; Prostaglandins; Rats; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Substance P; Urinary Bladder | 1993 |
Altered vascular permeability responses to substance P in diabetic rats: interactions with a nitric oxide synthesis inhibitor.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Glucose; Blood Pressure; Capillary Permeability; Diabetes Mellitus, Experimental; Dinoprostone; Drinking; Injections, Intravenous; Male; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Substance P | 1993 |
Selective damage to sensorimotor perivascular nerves in the mesenteric vessels of diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Dopamine beta-Hydroxylase; Fluorescent Antibody Technique, Indirect; Male; Mesenteric Arteries; Mesenteric Veins; Neuropeptide Y; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1996 |
Effects of streptozotocin-induced diabetes and insulin treatment on substance P of the rat arterial wall.
Topics: Animals; Aorta, Thoracic; Arteries; Blood Glucose; Body Weight; Capsaicin; Diabetes Mellitus, Experimental; Insulin; Male; Rats; Rats, Sprague-Dawley; Substance P | 1996 |
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition.
Topics: Aldehyde Reductase; Animals; Antibody Specificity; Axons; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Galanin; Hypoglycemic Agents; Ileum; Immunohistochemistry; Insulin; Intestines; Male; Myenteric Plexus; Neurons; Neuropeptides; Phthalazines; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1996 |
Acrylamide-induced neuropathic changes in rat enteric nerves: similarities with effects of streptozotocin-diabetes.
Topics: Acrylamide; Acrylamides; Animals; Autonomic Pathways; Calcitonin Gene-Related Peptide; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Intestines; Male; Nerve Fibers; Neuropeptide Y; Norepinephrine; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1996 |
Streptozotocin-induced diabetes produces a decrease in pituitary substance P content and preprotachykinin mRNA.
Topics: Animals; Diabetes Mellitus, Experimental; Gene Expression Regulation; Hypoglycemic Agents; Image Processing, Computer-Assisted; In Situ Hybridization; Insulin; Male; Oligonucleotide Probes; Pituitary Gland; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tachykinins | 1996 |
Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Ganglia, Spinal; Gene Expression; In Situ Hybridization; Male; Neurons, Afferent; Neuropeptide Y; Neuropeptides; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Somatostatin; Streptozocin; Substance P | 1996 |
alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Nerve Growth Factors; Neuropeptide Y; Neuropeptides; Rats; Rats, Wistar; Recombinant Proteins; Sciatic Nerve; Stereoisomerism; Substance P; Thioctic Acid | 1997 |
L-arginine does not reverse impaired agonist-induced increases in macromolecular efflux during diabetes mellitus.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Dextrans; Diabetes Mellitus, Experimental; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Histamine; Inflammation Mediators; Macromolecular Substances; Male; Mesocricetus; Substance P | 1997 |
Kinin receptors in the diabetic mouse.
Topics: Acetylcholine; Animals; Bradykinin; Diabetes Mellitus, Experimental; Gastric Fundus; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Neurokinin A; Receptors, Tachykinin; Reference Values; Substance P | 1997 |
Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Insulin; Motor Neurons; Nerve Growth Factors; Nerve Regeneration; Neural Conduction; Neurons, Afferent; Neurotrophin 3; Rats; Receptor, trkA; RNA, Messenger; Sciatic Nerve; Substance P | 1997 |
Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
Topics: Animals; Benzofurans; Carbamates; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Gerbillinae; Glycine; Guinea Pigs; Humans; Male; Neurokinin-1 Receptor Antagonists; Pain; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 1998 |
A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Linolenic Acid; Male; Motor Neurons; Nerve Growth Factors; Neural Conduction; Neurons, Afferent; Neuropeptide Y; Rats; Rats, Wistar; Sciatic Nerve; Substance P; Thioctic Acid | 1998 |
A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats.
Topics: Animals; Baclofen; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dizocilpine Maleate; GABA Agonists; GABA-B Receptor Agonists; Hyperalgesia; Indoles; Isoindoles; Male; Neurokinin-1 Receptor Antagonists; Physical Stimulation; Pressure; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; Substance P | 1998 |
Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor.
Topics: Animals; Calcitonin Gene-Related Peptide; Capillary Permeability; Diabetes Mellitus, Experimental; Insulin; Male; Nerve Growth Factors; Rats; Rats, Wistar; Skin; Streptozocin; Substance P; Vasodilation | 1998 |
Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord.
Topics: Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Cell Size; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Glycated Hemoglobin; Immunohistochemistry; Male; Myelin Sheath; Nerve Fibers; Nerve Growth Factors; Neuropeptides; Proto-Oncogene Proteins; Radioimmunoassay; Rats; Rats, Inbred Lew; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Nerve Growth Factor; Spinal Cord; Substance P; Sural Nerve | 1998 |
Stimulation of nerve growth-factor and substance P expression in the iris-trigeminal axis of diabetic rats--involvement of oxidative stress and effects of aldose reductase inhibition.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Imidazoles; Imidazolidines; Iris; Male; Membrane Proteins; Monosaccharides; Nerve Growth Factors; Oxidative Stress; Polymers; Protein Precursors; Rats; Rats, Wistar; Receptor, trkA; RNA, Messenger; Sciatic Nerve; Substance P; Tachykinins; Trigeminal Ganglion | 1998 |
Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus.
Topics: Acetylcholine; Animals; Basilar Artery; Diabetes Mellitus, Experimental; Free Radical Scavengers; Male; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Streptozocin; Substance P; Thiourea; Vasodilation; Vasodilator Agents | 1998 |
Decreased sensory neuropeptide release from trachea of rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Glucose; Body Weight; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Electric Stimulation; In Vitro Techniques; Male; Neuropeptides; Radioimmunoassay; Rats; Rats, Wistar; Somatostatin; Substance P; Trachea | 1999 |
Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced diabetes in rats. III. Distribution of neuropeptides in normal and diabetic (host) pancreas.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Female; Immunohistochemistry; Male; Neuropeptide Y; Neuropeptides; Pancreas Transplantation; Rats; Rats, Wistar; Reference Values; Sincalide; Skin; Substance P; Transplantation, Heterologous; Vasoactive Intestinal Peptide | 1999 |
Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: protective action of antioxidant treatment.
Topics: Animals; Animals, Newborn; Antioxidants; Axonal Transport; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Progression; Embryonic and Fetal Development; Female; Gestational Age; In Situ Hybridization; Nerve Growth Factors; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Substance P | 1999 |
The effect of streptozotocin-induced diabetes mellitus on substance P and calcitonin gene-related peptide expression in the rat trigeminal ganglion.
Topics: Animals; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; In Situ Hybridization; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Time Factors; Trigeminal Ganglion; Up-Regulation | 1999 |
Endothelin and free radicals modulate microvascular responses in streptozotocin-induced diabetic rats.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Electric Stimulation; Endothelin Receptor Antagonists; Endothelins; Free Radicals; Laser-Doppler Flowmetry; Male; Microcirculation; Nitroprusside; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sciatic Nerve; Skin; Streptozocin; Substance P; Superoxide Dismutase; Vasodilator Agents | 2000 |
Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
Topics: Animals; Antibody Specificity; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Glucagon; Insulin; Nerve Fibers; Neuropeptide Y; Neuropeptides; Pancreas; Pancreatic Hormones; Pancreatic Polypeptide; Rats; Sincalide; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1999 |
Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Formaldehyde; Hindlimb; Hot Temperature; Pain; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Reference Values; Spinal Cord; Substance P | 2000 |
Distribution of NPY and SP and their effects on glucagon secretion from the in vitro normal and diabetic pancreatic tissues.
Topics: Animals; Culture Techniques; Diabetes Mellitus, Experimental; Glucagon; Immunohistochemistry; Islets of Langerhans; Male; Neuropeptide Y; Pancreas; Radioimmunoassay; Rats; Rats, Wistar; Substance P | 2000 |
Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Insulin; Insulin Secretion; Male; Neuropeptide Y; Pancreas; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 2001 |
Clenbuterol stimulates neurotrophic support in streptozotocin-diabetic rats.
Topics: Animals; Biological Transport, Active; Calcitonin Gene-Related Peptide; Clenbuterol; Diabetes Mellitus, Experimental; Hindlimb; Homeostasis; Male; Muscle, Skeletal; Nerve Growth Factors; Rats; Rats, Wistar; Sciatic Nerve; Substance P | 1999 |
Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina.
Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2001 |
Changes in paw oedema triggered via bradykinin B(1) and B(2) receptors in streptozotocin-diabetic rats.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Dinoprostone; Edema; Hindlimb; Hypoglycemic Agents; Insulin, Long-Acting; Male; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Substance P; Time Factors | 2001 |
Effect of diabetic state on co-localization of substance P and serotonin in the gut in animal models.
Topics: Animals; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Digestive System; Duodenum; Enteroendocrine Cells; Female; Image Processing, Computer-Assisted; Immunohistochemistry; Intestinal Mucosa; Male; Mice; Mice, Inbred NOD; Mice, Obese; Prediabetic State; Pyloric Antrum; Serotonin; Substance P | 2001 |
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Linolenic Acid; Male; Nerve Growth Factor; Neural Conduction; Neurons; Neuropeptide Y; Oxidative Stress; Phenotype; Primaquine; Rats; Rats, Wistar; Sciatic Nerve; Substance P; Thioctic Acid; Vitamin E | 2001 |
Gastric neuropeptides and gastric motor abnormality in streptozotocin-induced diabetic rats: observation for four weeks after streptozotocin.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Gastric Emptying; Gastric Mucosa; Insulin; Male; Rats; Rats, Wistar; Streptozocin; Substance P; Time Factors | 2001 |
Feeble bronchomotor responses in diabetic rats in association with decreased sensory neuropeptide release.
Topics: Animals; Blood Glucose; Body Weight; Bronchial Hyperreactivity; Bronchoconstriction; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Guinea Pigs; Insulin; Male; Neural Conduction; Neurons, Afferent; Ovalbumin; Rats; Rats, Wistar; Somatostatin; Substance P; Trachea | 2002 |
Diabetes-induced changes in responsiveness of rat bladder and vas deferens to peptides in vitro: susceptibility to reversal by insulin.
Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Insulin; Male; Peptides; Rats; Rats, Wistar; Receptors, Bradykinin; Substance P; Urinary Bladder; Vas Deferens | 2002 |
Antinociceptive effect of mexiletine in diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Mexiletine; Mice; Mice, Inbred ICR; Nociceptors; Pain; Potassium; Reaction Time; Substance P | 1992 |
Effect of substance P on detrusor muscle in rats with diabetic cystopathy.
Topics: Animals; Diabetes Mellitus, Experimental; Muscle Contraction; Muscles; Pressure; Rats; Rats, Sprague-Dawley; Substance P; Urinary Bladder; Urinary Bladder Diseases; Urination; Urodynamics | 1992 |
Early neurochemical changes in the autonomic neuropathy of the gut in experimental diabetes.
Topics: Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; GTP-Binding Proteins; Intestinal Mucosa; Intestines; Male; Neuropeptides; Rats; Rats, Sprague-Dawley; Serotonin; Signal Transduction; Substance P; Vasoactive Intestinal Peptide | 1992 |
Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Intestinal Mucosa; Intestines; Male; Neuropeptides; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 1992 |
Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lumbar Vertebrae; Male; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P | 1992 |
Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Fluorenes; Fructose; Glucose; Hydantoins; Inositol; Insulin; Male; Rats; Rats, Inbred Strains; Sciatic Nerve; Sorbitol; Substance P | 1992 |
Effects of age and streptozotocin-induced diabetes on contents and effects of substance P and vasoactive intestinal polypeptide in the lower urinary tract of the rat.
Topics: Aging; Animals; Diabetes Mellitus, Experimental; Female; In Vitro Techniques; Rats; Rats, Inbred Strains; Substance P; Urethra; Urinary Bladder; Urinary Tract; Vasoactive Intestinal Peptide | 1992 |
Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Pain; Rats; Rats, Inbred Strains; Sensory Thresholds; Spinal Cord; Substance P | 1990 |
Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozocin-diabetic rat ileum.
Topics: Adrenergic Fibers; Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Dopamine beta-Hydroxylase; Ileum; Immunohistochemistry; Male; Myenteric Plexus; Nerve Fibers; Neurons; Neuropeptide Y; Rats; Rats, Inbred Strains; Streptozocin; Submucous Plexus; Substance P; Vasoactive Intestinal Peptide | 1990 |
Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats.
Topics: Animals; Axonal Transport; Diabetes Mellitus, Experimental; Ganglia, Spinal; Gangliosides; Immunohistochemistry; Ligation; Male; Rats; Rats, Inbred Strains; Sciatic Nerve; Streptozocin; Substance P | 1990 |
Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fluorescent Antibody Technique; Male; Nerve Fibers; Neuropeptide Y; Neuropeptides; Rats; Rats, Inbred Strains; Skin; Substance P; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1990 |
Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuli.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Hot Temperature; Male; Mice; Mice, Inbred ICR; Neurons; Pain; Physical Stimulation; Reaction Time; Sensory Thresholds; Somatostatin; Spinal Cord; Substance P; Synaptic Transmission | 1991 |
Changes of substance P and somatostatin contents in the gastrointestinal tract of streptozotocin diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Digestive System; Organ Size; Radioimmunoassay; Rats; Rats, Inbred Strains; Somatostatin; Substance P | 1991 |
Alterations in the potassium-evoked release of substance P from the spinal cord of streptozotocin-induced diabetic rats in vitro.
Topics: Animals; Bucladesine; Cyclic AMP; Diabetes Mellitus, Experimental; Glucose; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Male; Morphine; Nociceptors; Potassium; Rats; Rats, Inbred Strains; Spinal Cord; Substance P; Synaptic Transmission | 1991 |
Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat.
Topics: Animals; Diabetes Mellitus, Experimental; Digestive System; Duodenum; Gastric Mucosa; Ileum; Intestine, Small; Jejunum; Male; Niacinamide; Organ Size; Rats; Rats, Inbred Strains; Somatostatin; Stomach; Streptozocin; Substance P; Tissue Distribution; Vasoactive Intestinal Peptide | 1985 |
Enteric nerves in diabetic rats: increase in vasoactive intestinal polypeptide but not substance P.
Topics: Animals; Colon; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Histocytochemistry; Ileum; Intestinal Mucosa; Intestines; Male; Muscle, Smooth; Myenteric Plexus; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1985 |
Reduced neurogenic inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Inflammation; Male; Microcirculation; Nerve Tissue Proteins; Nociceptors; Rats; Rats, Inbred Strains; Somatostatin; Substance P | 1985 |
Substance P and somatostatin content and transport in vagus and sciatic nerves of the streptozocin-induced diabetic rat.
Topics: Animals; Axonal Transport; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Rats; Rats, Inbred Strains; Sciatic Nerve; Somatostatin; Substance P; Vagus Nerve | 1987 |
Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats.
Topics: Acetylcholine; Animals; Calcitonin; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Electric Stimulation; Ileum; Male; Nerve Fibers; Neuropeptides; Rats; Rats, Inbred Strains; Serotonin; Splanchnic Nerves; Substance P; Vasoactive Intestinal Peptide | 1987 |
Histochemical and biochemical investigation of adrenergic, cholinergic and peptidergic innervation of the rat ventral prostate 8 weeks after streptozotocin-induced diabetes.
Topics: Adrenergic Fibers; Animals; Cholinergic Fibers; Diabetes Mellitus, Experimental; Histocytochemistry; Immunoassay; Male; Neuropeptide Y; Neuropeptides; Prostate; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1987 |
Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Topics: Aldehyde Reductase; Animals; Axonal Transport; Body Weight; Diabetes Mellitus, Experimental; Ganglia, Spinal; Gastric Mucosa; Ileum; Male; Phthalazines; Pyridazines; Rats; Rats, Inbred Strains; Stomach; Substance P; Sugar Alcohol Dehydrogenases; Trigeminal Ganglion; Trigeminal Nerve | 1987 |
Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats.
Topics: Animals; Blood Glucose; Body Water; Carbohydrates; Diabetes Mellitus, Experimental; Male; Rats; Rats, Inbred Strains; Sciatic Nerve; Streptozocin; Substance P; Vasoactive Intestinal Peptide | 1988 |
Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin.
Topics: Animals; Axons; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glucose; Imidazoles; Imidazolidines; Insulin; Ligation; Male; Neurons; Rats; Rats, Inbred Strains; Substance P | 1988 |
Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats.
Topics: Animals; Calcitonin; Calcitonin Gene-Related Peptide; Colon; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Male; Myenteric Plexus; Nerve Fibers; Neuropeptides; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Streptozocin; Substance P; Vasoactive Intestinal Peptide | 1988 |
An increase of vasoactive intestinal polypeptide-, but not neuropeptide Y-, substance P- or catecholamine-containing nerves in the iris of the streptozotocin-induced diabetic rat.
Topics: Adrenergic Fibers; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Iris; Male; Nerve Fibers; Neuropeptide Y; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1988 |
Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes; changes in lens and in substance P and catecholamines in the iris.
Topics: Animals; Blood Glucose; Body Weight; Catecholamines; Diabetes Mellitus, Experimental; Epinephrine; Imidazoles; Imidazolidines; Inositol; Iris; Lens, Crystalline; Male; Norepinephrine; Rats; Rats, Inbred Strains; Sciatic Nerve; Substance P; Time Factors; Trigeminal Ganglion | 1989 |
Acetylcholine and substance P responsiveness of intestinal smooth muscles in streptozotocin diabetic rats.
Topics: Acetylcholine; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Intestines; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains; Substance P | 1988 |
Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Digestive System; Heart Atria; Imidazoles; Imidazolidines; Inositol; Male; Myocardium; Peripheral Nerves; Rats; Rats, Inbred Strains; Skin; Streptozocin; Substance P; Time Factors | 1989 |
Effect of age and methacholine on the rate and coronary flow of isolated hearts of diabetic rats.
Topics: Aging; Animals; Atropine; Blood Glucose; Body Weight; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Heart Rate; In Vitro Techniques; Male; Methacholine Compounds; Organ Size; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance P; Time Factors | 1989 |
Denervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy.
Topics: Animals; Biogenic Monoamines; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Male; Neuropeptides; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1989 |